Anzeige
Mehr »
Login
Dienstag, 25.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien
Mega-Chance Palladium: Europäischer Palladiumjunior von der Masse noch völlig unentdeckt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0HG6G ISIN: SE0000736415 Ticker-Symbol: C5G 
Frankfurt
24.02.20
08:29 Uhr
5,760 Euro
-0,120
-2,04 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OREXO AB Chart 1 Jahr
5-Tage-Chart
OREXO AB 5-Tage-Chart
RealtimeGeldBriefZeit
5,470
5,560
24.02.

Aktuelle News zur OREXO Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiInvitation - Orexo Capital Markets Day, Stockholm, Sweden, March 17255UPPSALA, Sweden, Feb. 19, 2020 /PRNewswire/ -- Orexo AB (publ.), today invites investors, analysts and media to attend the company's Capital Markets Day, taking place in Stockholm, Sweden...
► Artikel lesen
OREXO Aktie jetzt für 4€ handeln
17.02.Orexo AB (publ.) has Resolved to Carry out Repurchases of own Shares136UPPSALA, Sweden, Feb. 17, 2020 /PRNewswire/ -- The board of Orexo AB (publ.) has resolved, pursuant to the authorisation granted by the annual general meeting held on 11 April 2019, to initiate...
► Artikel lesen
06.02.Orexo - Zubsolv stabilizing enables R&D push96Orexo continues to weather the shift in its payer base away from exclusivity to the open market well. It has managed to maintain 4% sequential growth in Zubsolv sales from Q3 to Q419 (SEK190.5m), in...
► Artikel lesen
30.01.OREXO: Q4 incl. Full Year Report 20193
29.01.OREXO: Promising results from human PK study assessing novel ketorolac formulations for treatment of pain-
03.12.19Save the Date: Orexo to Host Capital Markets Day focusing on Digital Health, on March 17, 2020199UPPSALA, Sweden, Dec. 3, 2019 /PRNewswire/ -- Orexo AB (publ.), the fully integrated specialty pharmaceutical company with the aim of becoming a leader in the treatment of addiction, today...
► Artikel lesen
02.12.19Orexo Appoints Dennis Urbaniak as Executive Vice President Digital Health192- Appointment strengthens Orexo's competencies and resources within digital health - Orexo committed to finding innovative solutions to improve treatment of addiction UPPSALA, Sweden...
► Artikel lesen
27.11.19Orexo Acquires Exclusive US Rights to Commercialize Vorvida, a Digital Therapy for Alcohol Use Disorder with Scientifically Proven Efficacy279-Deal further strengthens Orexo's partnership with GAIA -Orexo committed to digital health to address addiction UPPSALA, Sweden, Nov. 27, 2019 /PRNewswire/ -- Orexo AB (publ)...
► Artikel lesen
21.11.19Orexo AB ADR (ORXOY) Presents At Jefferies Global Healthcare Conference - Slideshow-
08.11.19Orexo to Present at Jefferies 2019 Healthcare Conference202UPPSALA, Sweden , Nov. 8, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the company...
► Artikel lesen
31.10.19Orexo - Record quarter reflecting shifting US market156Orexo reported a record performance for Q319 with revenue of SEK231.2m (+6.7% year-on-year). The top line was lifted by a combination of factors including currency and a shift in the reimbursement landscape...
► Artikel lesen
24.10.19Orexo AB reports Q3 results2
24.10.19Orexo Interim Report Q3 2019266Orexo Interim Report Q3 2019 PR Newswire UPPSALA, Sweden, Oct. 24, 2019 Strong financials paving the way for broadening the business UPPSALA, Sweden, Oct. 24, 2019...
► Artikel lesen
14.10.19Orexo's Nomination Committee for the Annual General Meeting 2020291UPPSALA, Sweden, Oct. 14, 2019 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) in 2020, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the...
► Artikel lesen
21.08.19Orexo - Bringing AI to the treatment of OUD177Orexo has announced a partnership for the digital therapy of opioid use disorder (OUD) with GAIA, a global leader in digital therapeutics. The partnership will use GAIA's expert system technology platform...
► Artikel lesen
20.08.19Orexo Signs Partnership Agreement With GAIA AG to Develop and Commercialize a new Digital Therapy for the Treatment of Opioid Use Disorder410UPPSALA, Sweden, Aug. 20, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces it has entered into...
► Artikel lesen
15.07.19Orexo - By leaps and bounds63After a strong Q119, which is seasonally the weakest quarter, Orexo also had a higher bar to beat Q218 due to milestone income making it one of its best ever quarters. Nevertheless, total Q219 revenues...
► Artikel lesen
11.07.19Orexo Interim Report Q2 201976Improving all fundamentals UPPSALA, Sweden, July 11, 2019 /PRNewswire/ -- Q2 2019 highlights Total net revenues of SEK 201.2 million (199.7), up 0.8 percent and 19.1...
► Artikel lesen
10.07.19Orexo Signs License and Supply Agreement With Mundipharma for Zubsolv in Australia and New Zealand73UPPSALA, Sweden, July 10, 2019 /PRNewswire/ -- Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces the company has...
► Artikel lesen
09.07.19Orexo Prepays Part of the Corporate Bond Loan66UPPSALA, Sweden , July 9, 2019 /PRNewswire/ --Orexo AB (publ.) has resolved to prepay SEK 32.5 million, corresponding to 10 percent, of the unsecured corporate bond loan of in total SEK 325...
► Artikel lesen
Seite:  Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1